In recent news,
Clorox CFO, Kevin Jacobsen, announced his retirement with
Luc Bellet named as successor. Various investment advisory firms have decreased or increased positions in The
Clorox Company (NYSE:CLX), including TCI Wealth Advisors Inc., Forsta AP Fonden, and KBC Group NV among others, indicating a dynamic trading environment. Despite earnings estimates suggesting positive performance, analysts have offered mixed reviews, with a noted rating downgrade against other Consumer Staples Stocks. However, there is a belief that the intrinsic value of the company is potentially 65% above its current share price. As
Q2 earnings approach there's speculation on whether the cleaning materials company is the best investment opportunity in its sector.
Divestiture of its Better Health VMS Business was completed, alongside announcements about management changes and board member appointments. The company is expecting a Q2 earnings release, with CEO and CFO hosting an analyst call on February 3, and has increased its quarterly dividend to
$1.22 per share. Clorox's commitment to innovation is clear, recently hitting its 100M consumer goal and unveiling plans for a digital transformation.
Clorox Company CLX News Analytics from Thu, 21 Mar 2024 07:00:00 GMT to Sat, 01 Feb 2025 14:20:57 GMT -
Rating 3
- Innovation 0
- Information 2
- Rumor -7
